
Google DeepMind announced its AlphaFold Protein Database now serves over 3 million researchers across 190 countries. CEO Demis Hassabis and Google SVP James Manyika detailed this expansion in a Fortune commentary preceding the India AI Impact Summit in New Delhi. They emphasized AI’s role in addressing global challenges, noting over one-third of users reside in low- and middle-income nations. The database provides free access to structural data, facilitating widespread scientific collaboration.
The AlphaFold system resolves a half-century-old challenge: predicting protein structures from amino acid sequences. This capability earned Hassabis and colleague John Jumper the 2024 Nobel Prize in Chemistry. The database contains over 240 million structural predictions, covering nearly all known proteins. This volume of data represents work that would require hundreds of millions of years to complete experimentally, fundamentally altering the pace of biological research.
Researchers utilize AlphaFold to address specific regional and global health issues. Scientists at the National University of Malaysia are studying Melioidosis, a bacterial infection more lethal than dengue. In India, researchers at the Birla Institute of Technology and Science are applying the database to breed soybeans resistant to charcoal rot. These applications demonstrate the technology’s utility in agriculture and infectious disease research.
DeepMind is expanding its portfolio of scientific AI tools beyond protein structure prediction. The company developed an AI co-scientist designed to generate novel research hypotheses. Additionally, EarthAI supports environmental monitoring and disaster response efforts. AlphaGenome, recently published in Nature, predicts cancer-fueling mutations, offering new avenues for oncology research.
In healthcare diagnostics, DeepMind’s AI model for diabetic retinopathy detection has facilitated 600,000 screenings globally. Partnerships established in India and Thailand aim to expand this screening volume to 6 million individuals over the next ten years. These initiatives seek to integrate AI into public health infrastructure to improve accessibility.
The India AI Impact Summit, scheduled for February 19-20, represents the first global AI summit hosted by a Global South nation. Hassabis and Manyika stressed the necessity of international collaboration to ensure AI benefits are shared equitably. Their commentary articulated a goal to make AI universally accessible, enabling scientific breakthroughs to emerge from diverse regions worldwide.